News in brief: Sleep problems common in AS; Tocilizumab gets official TGA approval for COVID-19 treatment; Dual biologics approach for recalcitrant PsA

Sleep problems common in AS Good ankylosing spondylitis (AS) control may be key to improving patients’ sleep and quality of life beyond traditional disease activity measures, Australian rheumatologists suggest. A study of 495 AS patients who completed at least one sleep questionnaire between January 2019 and September 2020 found one third had self-reported apnoea and ...

Already a member?

Login to keep reading.

© 2022 the limbic